campesterol has been researched along with Carcinoma, Hepatocellular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Arockia Jeya Yasmi Prabha, E; Lakshmi, A; Langeswaran, K; Sangavi, P; Sangeetha, R | 1 |
| Chaikitwattana, A; Porter, JB; Prommaban, A; Srichairatanakool, S; Utama-Ang, N; Uthaipibull, C | 1 |
| Ho, SS; Pal, S | 1 |
3 other study(ies) available for campesterol and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Molecular docking and dynamic simulations of
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Molecular Docking Simulation; Molecular Dynamics Simulation; Ocimum basilicum | 2022 |
Phytosterol, Lipid and Phenolic Composition, and Biological Activities of Guava Seed Oil.
Topics: Animals; Antioxidants; Carcinoma, Hepatocellular; Cholesterol; Female; Hexanes; Liver Neoplasms; Male; Oxidative Stress; Phenols; Phytosterols; Plant Extracts; Plant Oils; Psidium; Rats; Seeds; Sitosterols; Triglycerides | 2020 |
Margarine phytosterols decrease the secretion of atherogenic lipoproteins from HepG2 liver and Caco2 intestinal cells.
Topics: Anticholesteremic Agents; Apolipoprotein B-100; Apolipoprotein B-48; Apolipoproteins B; Atherosclerosis; Atorvastatin; Caco-2 Cells; Carcinoma, Hepatocellular; Cholesterol; Drug Synergism; Enterocytes; Hepatocytes; Heptanoic Acids; Humans; Liver Neoplasms; Margarine; Phytosterols; Pyrroles; Sitosterols; Stigmasterol | 2005 |